Current guidelines seem to be based on the assumption that there exists an acute high-risk phase of follow-up.
The results of Beneciuk et al. support this perspective, as they specifically analyzed the relevance of the timing of the SBT and found that especially in acute high-risk patients, tool scores often change within a few weeks.
Likewise, patients with acute myeloid leukemia, high risk lymphatic leukemia, B-non-Hodgkin's lymphoma, relapse of acute leukemia, or patients undergoing bone marrow transplantation were treated with Ceftazidime.
Leukemia recurs most frequently in patients with acute myeloblastic leukemia (AML) and high risk acute lymphoblastic leukemia (ALL) following chemotherapy and less often in patients with low risk ALL and particularly in patient groups> submitted to allogeneic marrow transplantation.
Aversa, A. Terenzi, A. Tabilio, et al., Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse, J. Clin.
Almost all patients included in the acute group were high risk patients, 53% having TIMI risk score ≥3, maximal Tn I levels were of 5.1±6.1 ng/mL and maximal CPK-MB of 30.2±39.1 IU/L.
A key area to benefit was the prevention and management of acute exacerbations in high risk patients.
This meta-analysis indicates that elevated BNP levels can identify patients with acute PE at high risk of short-term death and adverse outcome events.
This meta-analysis indicates that elevated BNP or NT-proBNP levels can help to identify patients with acute PE at high risk of short-term death and adverse outcome events.
To determine, in women transferred antenatally for acute admission with high risk pregnancies, the numbers who deliver, the average time from transfer to delivery, and whether the reason for transfer influences the time-to-delivery.
In medically unresponsive cases of acute PAC, higher risk of surgical failure and complications make trabeculectomy not a preferred choice [ 17].
